Top compounds associated with response to RP13-210D15.9


Feature Type Standardized
Nominal ANOVA
mRNA RO4929097 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA procarbazine CTRPv2 pan-cancer AAC -0.008 0.8
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.0066 0.8
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.0065 0.8
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0074 0.8
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.014 0.8
mRNA HLI 373 CTRPv2 pan-cancer AAC 0.007 0.8
mRNA MS-275 CTRPv2 pan-cancer AAC -0.0063 0.8
mRNA TAE684 CTRPv2 pan-cancer AAC -0.0068 0.8
Download CSV